insights_auto
Outlook: 68.4% bullish·0.0% bearish
Go to analysischevron_right
XENE:NASDAQ
Xenon Pharmaceuticals Inc
$41.29
arrow_downward
-1.92%(-0.81) 1D
Nov 12, 2:55:23 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for XENE...
Open
$42.05
High
$42.20
Low
$40.62
Mkt. cap
4.06B
Avg. vol.
1.53M
Volume
606.70K
52-wk high
$72.66
52-wk low
$33.38
EPS
-$4.70
Beta
0.11
Shares outstanding
98.28M
No. of employees
364
Open
$42.05
High
$42.20
Low
$40.62
Mkt. cap
4.06B
Avg. vol.
1.53M
Volume
606.70K
52-wk high
$72.66
52-wk low
$33.38
EPS
-$4.70
Beta
0.11
Shares outstanding
98.28M
No. of employees
364
News stories
From web sources and news partners
The Globe and Mail
·
8 hours ago
Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Veeva Systems (VEEV) and Liquidia Technologies (LQDA)
Investing.com Canada
·
1 day ago
Xenon Pharmaceuticals at Guggenheim conference: launch plans take shape By Investing.com
Yahoo Finance
·
2 days ago
Xenon Pharmaceuticals Inc. Q3 2026 Earnings Call Summary
About Xenon Pharmaceuticals Inc
CEO-
Employees364
Founded1996
HeadquartersVancouver, British Columbia, Canada
SectorHealth Care
IndustryBiotechnology
Websitexenon-pharma.com